한국어
English
Archive
Year
Class/Forum
Presentation Title
Speaker
Lecture Video
KOR
ENG
GBC 2021
Keynote & Plenary
Keynote Speech
A Personalized Approach to Immune Therapies for Cancer: One drug, one patient
Larry Kwak
Deputy director of City of Hope's comprehensive cancer center,
City of Hope
GBC 2021
Keynote & Plenary
Keynote Speech
Harnessing Science to Address Unmet Medical and Public Health Needs: Why Regulation Matters
Margaret Hamburg
Interim Vice President,
Nuclear Threat Initiative
GBC 2021
Keynote & Plenary
Keynote Speech
A Preclinical Strategy to Improve Clinical Success Rates of Cancer Drug Development
Robert Kerbel
Senior scientist,
Sunnybrook Health Sciences Centre
GBC 2021
Keynote & Plenary
Keynote Speech
Regulatory agility and the response to public health threats: a changing environment”
Rogério Gaspar
Director,
WHO
GBC 2021
Keynote & Plenary
Keynote Speech
COVID-19: challenge an opportunity
Peter Doherty
Peter Doherty Institute at the University of Melbourne,
Professor
GBC 2021
Keynote & Plenary
Keynote Speech
The ubiquitin proteolytic system – from mechanisms to the patient bed and what it takes to make this road
Aaron Ciechanover
N/A,
Technion-Israel Institute of Technology
GBC 2021
Keynote & Plenary
Plenary Session
An Overview of the United States Government Program on COVID-19 vaccines
Lawrence Corey
Professor,
Fred Hutchinson Cancer Research Center
GBC 2021
Keynote & Plenary
Plenary Session
Challenge and Response to COVID-19
Jong-koo Lee
Professor ,
서울대학교 병원
GBC 2021
Vaccine
Vaccine Forum
Overview of mRNA vaccine development and six points to consider when doing research
Jae-Hwan Nam
professor,
The Catholic University of Korea
GBC 2021
Vaccine
Vaccine Forum
COVID 19 Vaccine Development
Jerome Hahn Kim
Director General,
International Vaccine Institute
GBC 2021
Vaccine
Vaccine Forum
The past and future of regulatory treatment of COVID-19 vaccines - From the initial licensure to future approval of adapted vaccines and indications
Ralf Wagner
Head of section for viral vaccines,
Paul-Ehrlich-Institut
GBC 2021
Vaccine
Vaccine Forum
Challenges in improving global access and equity to COVID-19 vaccines
Jinho Shin
Medical Officer,
WHO
GBC 2021
Vaccine
Vaccine Forum
COVID 19 vaccine development and the future strategy based on mRNA
Randall Hyer
Senior Vice President,
Moderna
GBC 2021
Recombinant Protein Products
Recombinant Protein Products Forum
Current Perspectives on antibody therapeutics for COVID-19
Junho Chung
Professor,
Seoul National University College of Medicine
GBC 2021
Recombinant Protein Products
Recombinant Protein Products Forum
Regulatory Approaches to CMC Development During COVID-19: Challenges and Opportunities
Marjorie Shapiro
Supervisory Biologist,
OBP/OPQ/CDER/FDA
